Recent studies on animal models have confirmed its role in RPE homeostasis and retinal health, providing insights on considering PROM1 a target for potential future therapeutic strategies, not only for IRDs, but also for age-related macular degeneration (AMD) [9]. This evidence concerns the gene PROM1 and respiratory distress syndrome in premature infants.